By David Mildenberg In BlogPosted September 9, 2017Post-hurricane building prospects boosts Jeld-Wen, Lowe’sG1 Therapeutics is on fire with investors obviously excited about the company's anti-cancer drugs, soaring more than 30% last week. READ MORE
